Delivery Order SPE2DB22D2214-SPE2DB25FS4DD
- Not listed
- This federal contract award, valued at $2,149.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,142,826 potassium chloride extended-release tablets, 500 tablets per bottle. The contract is not set aside and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of potassium chloride extended-release capsules, a critical medication for various medical conditions. The contract has a ceiling value of $3,641.65 and a completion date of September 16, 2024. There is no set-aside designation...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,096.38 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 8 MEQ tablets. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- This federal contract award, valued at $2,866.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24FQZ54) for the supply of 4565097121 - Potassium Chloride Extended Release 20 MEQ Tablets in 500-count packages. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $4,210.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The DO covers the supply of 4566759644 POTASSIUM CL ER 8 MEQ TABLET 500S, a pharmaceutical product, with an...
- The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,611.86. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,146.36 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Potassium Chloride 10 milliequivalents per 100 milliliters solution in 100-milliliter units. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The provided information describes a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,192.10, is a Firm Fixed Price Delivery Order for the supply of Potassium Chloride 10 MEQ/100 ML Solution 100 ML. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS4DDDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,199.81, is for the delivery of potassium chloride extended-release tablets. It is a firm fixed-price delivery order contract with a period of performance through March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is likely a task order or delivery order under that IDC. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/10/25 |